This page is taking to long to load, please try later Net gains against malaria by MedAccess
Skip to content
Home
10%

Net gains against malaria

A decades-long battle with insecticide-resistant mosquitos

MedAccess
By MedAccess

© 2024 MedAccess

MedAccess is a social enterprise committed to improving health in more than 90 countries. Our mission is to cut illness and death by speeding up access to lifesaving vaccines, medicines, diagnostics and technologies for people in underserved communities.
Using $200 million capital from British International Investment, our agile team of global health and investment experts shapes agreements that break down the barriers preventing people from accessing medical innovations.
By subscribing to the mailing list of MedAccess your email address is stored securely, opted into new post notifications and related communications. We respect your inbox and privacy, you may unsubscribe at any time.
Loading, please hold on.